Published Wed, 01 Aug 2018 20:18:44 -0400 on Seeking Alpha
Actionable Conclusions (1-10): Brokers Estimated Top Ten High Yield Healthcare "Safer" Dividend Stocks to Net 11.75% to 22.98% Gains To July 2019 Three of ten top 'safer' dividend Healthcare stocks by yield (shaded in the chart above) were verified as being among the top ten gainers for the coming year. Thus, based on analyst 1-year target prices, the dog strategy for this Health group graded out as 30% accurate in July.
Projections based on estimated dividends from $1000 invested in the ten highest yielding Healthcare stocks, and aggregate one-year analyst mean target prices for those stocks, as reported by YCharts, created the 2019 data points. Note: one-year target prices from one analyst were not applied (n/a).Ten probable profit-generating trades to 2019 were:
McKesson (MCK) netted $229.88 based on estimates from eighteen analysts plus dividends, less broker fees. The Beta number showed this estimate subject to volatility 29% more than the market as a whole.
AbbVie (ABBV) netted $209.52 based on a median target price estimate from twenty-three analysts plus dividends, less broker fees. The Beta number showed this estimate subject to volatility 61% more than the market as a whole.
AmerisourceBergen (ABC) netted $200.84 based on estimates from eighteen analysts plus dividends, less broker fees. The Beta number showed this estimate subject to volatility 4% over the market as a whole.
Sanofi (SNY) netted $164.74 based on a median of estimates... Read more
|Stock name||Last trade||P/E||Earnings/Share||Dividend/Share||Dividend yield|
|JOHNSON & JOHNSON||130.43||21.6||6.03||3.80||2.93|
|FRESENIUS MEDICAL CARE||34.62||15.0||2.30||0.45||1.29|
|NOVO NORDISK A/S||49.67||20.8||2.39||0.64||1.28|
Older articles featuring Abbvie (ABBV):27 Durable Dividend Dogs For Our Times: The May Uprising
Health Care Select Sector SPDR ETF: Consistent Dividend Growth And Better Growth Profile Than The S&P 500
HIE: Near 4% Annual Alpha From This High Dividend Equity Closed-End Term Fund
My Dividend Growth Portfolio April Update: 41 Holdings, 0 Buys, 10 Sells
Dividend Challenger Highlights: Week Of May 10
Coronavirus Roundtable - Quality Pays For Dividend Investors (Video)
5%+ Dividend Yield Portfolio: Bracing For The Retest (April 2020 Review)
Looking For Double-Digit Dividend Growth In Today's Uncertain Times
The 13 Best Dividend Aristocrats To Buy In This Uncertain Economy
Dividend Challenger Highlights: Week Of April 12